Akers Biosciences (AKER) Reports Q2 Loss of $0.41/Share

Akers Biosciences (NASDAQ: AKER) reported Q2 EPS of ($0.41), versus ($0.10) reported last year. Revenue for the quarter came in at $966.9 thousand, versus $1.35 million reported last year.

For earnings history and earnings-related data on Akers Biosciences (AKER) click here.

You May Also Be Interested In

• Broadcom credit risk measures rise amid AI financing deals
• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• Freedom Broker Starts Citizens Inc. (CIA) at Buy